Rezurock
NDC 79802-200, belumosudil, tablet, from Kadmon Pharmaceuticals, LLC.
- Product NDC
- 79802-200
- Status
- Listed
- Labeler
- Kadmon Pharmaceuticals, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA214783
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/79802-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BELUMOSUDIL200 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 79802-200-30 | 79802020030 | 1 BOTTLE in 1 CARTON (79802-200-30) / 30 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/102e4ef4-7f84-4e34-8df1-479c24d1575d
Use it
Look up 79802-200 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/79802-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 79802-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.